Table: Takara Bio -2025/26 group results
May 13 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 40.32 45.04 44.00 19.90
(-10.5 pct) (+3.5 pct) (+9.1 pct) (+5.9 pct)
Operating loss 4.69 2.26 loss 2.70 loss 2.35
(-24.6 pct)
Recurring loss 4.99 2.59 loss 3.00 loss 2.50
(-23.9 pct)
Net
Net loss 9.60 1.04 loss 6.40 loss 4.45
(-29.6 pct)
EPS loss 79.72 yen 8.65 yen loss 53.15 yen loss 36.96 yen
Ann Div NIL 17.00 yen
-Q2 Div NIL NIL
-Q4 Div NIL 17.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T